Tag Archives: NASDAQ:SLS

Maxim Group Keeps a Buy Rating on SELLAS Life Sciences Group Inc (SLS)

Maxim Group analyst Jason McCarthy maintained a Buy rating on SELLAS Life Sciences Group Inc (NASDAQ: SLS) today and set a price target of $5. The company’s shares opened today at $1.99, close to its 52-week low of $0.80. McCarthy

SELLAS Life Sciences Group Inc Gets a Buy Rating from Maxim Group

In a report released today, Jason McCarthy from Maxim Group assigned a Buy rating to SELLAS Life Sciences Group Inc (NASDAQ: SLS), with a price target of $13. The company’s shares opened today at $6.60. McCarthy said: “The prior interim

Maxim Group Thinks SELLAS Life Sciences Group Inc’s Stock is Going to Recover

In a report released today, Jason McCarthy from Maxim Group maintained a Buy rating on SELLAS Life Sciences Group Inc (NASDAQ: SLS), with a price target of $13. The company’s shares opened today at $5.66, close to its 52-week low